Product Information
Treatment of neovascular (wet) age-related macular degeneration (AMD). Treatment of diabetic macular edema (DME)
Active Ingredients - Brolucizumab
Product Division - Novartis Pharmaceuticals
Subcategory - Antineovascularization agents